Core Viewpoint - The Supreme People's Court is taking steps to address "involution" competition through judicial measures, focusing on regulating monopolistic behaviors and preventing large enterprises from squeezing the profit margins of small and medium-sized enterprises [1][3]. Group 1: Judicial Measures Against Involution Competition - The Supreme People's Court's Intellectual Property Court aims to explore judicial paths to comprehensively address "involution" competition, emphasizing the need to regulate predatory pricing and other exclusionary practices by dominant firms [1][3]. - The court has identified three main factors contributing to "involution" competition: monopolistic behaviors, insufficient innovation, and unfair competition practices [1]. Group 2: Actions Taken by the Intellectual Property Court - The court has increased the supply of competition rules and case studies, clarifying the boundaries of market behavior, and has published 34 typical cases related to monopolistic and unfair competition since 2021 [2]. - Judicial anti-monopoly efforts have intensified, with 66 cases recognized as monopolistic since the court's establishment, including 15 cases in 2025 [2][4]. - The court is focusing on protecting innovation and promoting high-quality competition by applying measures such as evidence preservation and punitive damages to combat patent infringements [2]. Group 3: Addressing Malicious Competition - The court is targeting malicious competition cycles by strictly regulating unfair competition behaviors, such as stealing trade secrets and organized poaching, to prevent downward competition spirals [2][3]. - In 2025, the court handled several high-profile cases in sectors like platforms, new energy, and pharmaceuticals, encouraging cooperation and innovation among leading enterprises [3]. Group 4: Strengthening Judicial and Administrative Coordination - The court is enhancing the integration of administrative enforcement and judicial adjudication, ensuring that antitrust violations identified in civil lawsuits are reported to enforcement agencies [4]. - Since its establishment, the court has effectively adjudicated 203 antitrust cases, with 66 cases confirmed as monopolistic, covering various sectors including pharmaceuticals, telecommunications, and e-commerce [4].

Core Viewpoint - The Supreme People's Court is addressing the issue of "involution" competition in the national unified market, emphasizing the need for judicial measures to regulate monopolistic and unfair competition behaviors [1] Group 1: Judicial Measures - The Supreme People's Court will explore deeper judicial paths to combat "involution" competition [1] - There will be a strict regulation of predatory pricing and other abusive market dominance behaviors by leading enterprises to protect the profit margins of small and medium-sized enterprises [1] - The court aims to regulate typical horizontal monopoly agreements such as fixed pricing and market division to restore a healthy competitive environment [1] Group 2: Administrative and Competitive Practices - The court will correct the abuse of administrative power that excludes or restricts competition, aiming to break local protectionism and industry barriers [1] - There will be an increased judicial protection for key frontier technology innovations and business secrets to enhance innovation and entrepreneurial vitality [1]

Core Insights - Major international AI companies are focusing on India, offering free advanced AI tools to millions, which has generated excitement but also concerns about monopolistic behavior and competition suppression [1][2] - The strategy of these companies is seen as a "bait-and-switch" marketing tactic aimed at creating dependency on generative AI before transitioning users to paid services [2] - India, with nearly 1 billion internet users, is a prime market for global tech companies to expand their user base and collect valuable data to enhance their AI models [2] Industry Analysis - The free services provided by international giants may lead to predatory pricing, raising anti-competitive concerns as it makes it difficult for local competitors to challenge market leaders [2] - India lacks homegrown AI platforms and models, with local products struggling to compete with Western and Chinese offerings, despite the government's push for AI development [3] - The Indian AI sector is still in its early stages, with significant challenges such as a shortage of skilled AI engineers, high operational costs, and the need for robust infrastructure to support AI development [3]

Group 1 - The phenomenon of "one drug, two prices" has emerged, where the same medication is priced significantly lower online compared to physical stores, raising questions about the pricing mechanisms in the pharmaceutical market [3][4] - A specific case highlighted a price difference where an antiviral oral solution was priced at 10.3 yuan online versus 29.8 yuan in-store, illustrating a price disparity exceeding three times [3][4] - The disparity is attributed to various factors, including platform subsidies, pricing strategies, and the operational costs associated with physical stores [6][8] Group 2 - Online platforms are engaging in aggressive pricing strategies, offering substantial subsidies to pharmacies to attract customers, which allows them to sell medications at prices below cost [6][8] - The pricing differences are also influenced by the inherent cost structures of online versus offline sales, with online platforms having lower fixed costs compared to physical stores [8][9] - The regional monopolistic nature of many local pharmacies contributes to higher prices in those areas, while online competition fosters lower prices due to a broader market reach [9][11] Group 3 - The long-term sustainability of the current pricing practices in pharmacies is questionable, as increasing transparency in drug pricing and enhanced regulatory oversight are expected to challenge the existing pricing disparities [11]

Group 1 - The core issue of low-price sales is its significant impact on market order and brand development, with complaints related to low-price sales increasing by 18% year-on-year in 2024 [1] - Low-price sales lead to a "price avalanche effect," causing a 40% decline in monthly sales for businesses maintaining original prices, forcing 70% of industry players to follow suit, resulting in a 12% drop in overall profit margins [3] - The prevalence of counterfeit products in low-price sales is alarming, with 35% of such products being fake, leading to a 200% increase in complaints for a major international beauty brand and a 27 percentage point drop in brand reputation within six months [3] Group 2 - Not all low-price sales are illegal; they must be assessed based on intent, market impact, and legal criteria, with examples of unfair competition including predatory pricing and counterfeit sales [4] - Legal low-price sales can occur under specific circumstances, such as managing perishable goods or promoting new products with a clear promotional period, as demonstrated by a supermarket increasing turnover of near-expiry goods by 60% [5][6] - The legal framework allows for price reductions based on cost savings or seasonal adjustments, provided they do not harm other businesses or disrupt market order [7]